Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Moroni

Showing results (311-320 of 332) with videos related to

Pageof 34
Sort By:
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|August 15, 1996
A randomized trial (ISS 901) of switching to didanosine versus continued zidovudine after the diagnosis of AIDSS Vella, M Floridia, L G Dally, et al.
AIDS (London, England)|June 16, 2001
When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA studyA Cozzi Lepri, A N Phillips, A d'Arminio Monforte, et al.
Journal of Clinical Microbiology|January 4, 2001
Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type 1M Pizzuto, M Piazza, D Senese, et al.
Sexually Transmitted Infections|April 5, 2001
Sexual behaviour of heterosexual individuals with HIV infection naive for antiretroviral therapy in ItalyE Girardi, M S Aloisi, D Serraino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2009
Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal womenAndrea Decensi, Chris Robertson, Aliana Guerrieri-Gonzaga, et al.
The Journal of Infectious Diseases|May 24, 2000
Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis studyC Mussini, P Pezzotti, A Govoni, et al.
AIDS (London, England)|April 26, 2000
Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve PatientsA d'Arminio Monforte, A C Lepri, G Rezza, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2000
Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial. The M/3331/0013B Study GroupV Joly, M Moroni, E Concia, et al.
Antiviral Therapy|January 26, 2002
Impact of mutations conferring reduced susceptibility to lamivudine on the response to antiretroviral therapyC F Perno, A Cozzi-Lepri, C Balotta, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 6, 2001
Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAARTA de A Monforte, R Bugarini, P Pezzotti, et al.
Pageof 34

Showing results (311-320 of 332) with videos related to

Sort By:
Pageof 34
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|August 15, 1996
A randomized trial (ISS 901) of switching to didanosine versus continued zidovudine after the diagnosis of AIDSS Vella, M Floridia, L G Dally, et al.
AIDS (London, England)|June 16, 2001
When to start highly active antiretroviral therapy in chronically HIV-infected patients: evidence from the ICONA studyA Cozzi Lepri, A N Phillips, A d'Arminio Monforte, et al.
Journal of Clinical Microbiology|January 4, 2001
Role of PCR in diagnosis and prognosis of visceral leishmaniasis in patients coinfected with human immunodeficiency virus type 1M Pizzuto, M Piazza, D Senese, et al.
Sexually Transmitted Infections|April 5, 2001
Sexual behaviour of heterosexual individuals with HIV infection naive for antiretroviral therapy in ItalyE Girardi, M S Aloisi, D Serraino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2009
Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal womenAndrea Decensi, Chris Robertson, Aliana Guerrieri-Gonzaga, et al.
The Journal of Infectious Diseases|May 24, 2000
Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis studyC Mussini, P Pezzotti, A Govoni, et al.
AIDS (London, England)|April 26, 2000
Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve PatientsA d'Arminio Monforte, A C Lepri, G Rezza, et al.
Antimicrobial Agents and Chemotherapy|October 19, 2000
Delavirdine in combination with zidovudine in treatment of human immunodeficiency virus type 1-infected patients: evaluation of efficacy and emergence of viral resistance in a randomized, comparative phase III trial. The M/3331/0013B Study GroupV Joly, M Moroni, E Concia, et al.
Antiviral Therapy|January 26, 2002
Impact of mutations conferring reduced susceptibility to lamivudine on the response to antiretroviral therapyC F Perno, A Cozzi-Lepri, C Balotta, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 6, 2001
Low frequency of severe hepatotoxicity and association with HCV coinfection in HIV-positive patients treated with HAARTA de A Monforte, R Bugarini, P Pezzotti, et al.
Pageof 34